大麻二酚产品随处可见，但人们应该使用它们吗？ - Suppr

Cannabidiol Products Are Everywhere, but Should People Be Using Them?

作者信息

Rubin Rita

出版信息

JAMA. 2019 Dec 10;322(22):2156-2158. doi: 10.1001/jama.2019.17361.

DOI:10.1001/jama.2019.17361

PMID:31746958

Abstract

摘要

相似文献

Cannabidiol Products Are Everywhere, but Should People Be Using Them?

JAMA. 2019 Dec 10;322(22):2156-2158. doi: 10.1001/jama.2019.17361.

The Role of Cannabidiol in Palliative Care #370.

J Palliat Med. 2019 Mar;22(3):337-338. doi: 10.1089/jpm.2018.0670.

Cannabis and cannabinoids.

Med Lett Drugs Ther. 2016 Aug 1;58(1500):97-8.

Sativex for the management of multiple sclerosis symptoms.

Issues Emerg Health Technol. 2005 Sep(72):1-4.

Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

Clin Ther. 2007 Sep;29(9):2068-79. doi: 10.1016/j.clinthera.2007.09.013.

Harper Grace's law: providing hope to suffering children and opportunity to the state.

J Miss State Med Assoc. 2014 Aug;55(8):273-5.

The CBD Dialectic in Mental Health: Benign and Powerful?

Psychiatr Serv. 2020 Jan 1;71(1):2-3. doi: 10.1176/appi.ps.201900394. Epub 2019 Oct 23.

Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.

J Diet Suppl. 2020;17(5):487-492. doi: 10.1080/19390211.2020.1796886. Epub 2020 Jul 25.

Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.

Epilepsy Behav. 2015 Jun;47:138-41. doi: 10.1016/j.yebeh.2015.04.009. Epub 2015 Apr 29.

Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Final order.

Fed Regist. 2018 Sep 28;83(189):48950-3.

引用本文的文献

Cannabidiol prescribing in the United States: An analysis of real-world data.

Drug Alcohol Depend Rep. 2024 Nov 22;13:100303. doi: 10.1016/j.dadr.2024.100303. eCollection 2024 Dec.

Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.

Lancet Reg Health Eur. 2023 Nov 10;35:100777. doi: 10.1016/j.lanepe.2023.100777. eCollection 2023 Dec.

Prevalence and Factors Associated With Vaping Cannabidiol Among US Adolescents.

JAMA Netw Open. 2023 Aug 1;6(8):e2329167. doi: 10.1001/jamanetworkopen.2023.29167.

Is CBD ready for prime time in sickle cell disease?

Blood. 2023 Jan 12;141(2):132-133. doi: 10.1182/blood.2022018393.

Cannabidiol exposures in the United States, National Poison Data System, July 2014-June 2021.

Clin Toxicol (Phila). 2023 Feb;61(2):123-130. doi: 10.1080/15563650.2022.2156881. Epub 2022 Dec 20.

Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease.

Blood. 2023 Jan 12;141(2):203-208. doi: 10.1182/blood.2022016382.

Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.

Cannabis Cannabinoid Res. 2022 Jun;7(3):345-354. doi: 10.1089/can.2020.0092. Epub 2020 Oct 29.

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients' Perspectives and Attitudes.

J Pain Res. 2021 May 5;14:1241-1250. doi: 10.2147/JPR.S278718. eCollection 2021.

Pain in sickle cell disease: current and potential translational therapies.

Transl Res. 2021 Aug;234:141-158. doi: 10.1016/j.trsl.2021.03.007. Epub 2021 Mar 9.

Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease.

J Clin Med. 2020 Dec 1;9(12):3902. doi: 10.3390/jcm9123902.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cannabidiol Products Are Everywhere, but Should People Be Using Them?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献